Europe

EMD Millipore opens GMP bioproduction facility in France

Tuesday, September 25, 2012 12:02 PM

EMD Millipore, the Billerica, Mass.-based life science division of Merck, has opened its advanced GMP bioproduction facility in Martillac, France, offering a full, single-use process train to speed a molecule’s journey to the clinic.

More... »

NW Bio appoints vet Rosskamp as CEO of German subsidiary

Friday, September 21, 2012 01:24 PM

Northwest Biotherapeutics, a biotech developing DCVaxR personalized immune therapies for cancer, has appointed former pharmaceutical industry executive Dr. Gunter Rosskamp as the CEO of the company's German subsidiary, Northwest Biotherapeutics, Gmbh.

More... »

Wellington Partners announces first closing of new life science fund

Thursday, September 20, 2012 07:31 AM

Wellington Partners, a pan-European venture capital firm, announced the successful first closing of its new Wellington Partners IV Life Science Fund, which has attracted commitments from investors of $91 million.

More... »

CureVac secures $104M in Series D financing

Wednesday, September 19, 2012 12:04 PM

CureVac, a German clinical stage biopharmaceutical company developing a new class of therapies and vaccines based on mRNA, today announced the completion of a $140 million financing round with its main investor, dievini Hopp BioTech Holding.

More... »

Mutabilis receives $5.2M from E.U. for HIVINNOV project

Wednesday, September 19, 2012 11:06 AM

Mutabilis, a spin-off from INSERM that focuses on therapeutics for treating serious, hospital-acquired infections, has received $5.2 million of European funding for the HIVINNOV project, aimed at developing new antiretrovirals against HIV.

More... »

UCB expands biotechnology base in Belgium

Monday, September 17, 2012 02:02 PM

In line with its strategy, and in preparation for the growing demand for biological medicines, UCB, a biopharma focused on the central nervous system and immune system, has opened its new pilot biotechnology plant at its Braine-L’Alleud site in Belgium.

More... »

Sartorius opens German production facility for bioreactors

Friday, September 14, 2012 12:19 PM

Sartorius, the Germany-based international laboratory and process technology provider, has officially opened its new plant in Guxhagen, Germany, for the manufacture of bioreactors.

More... »

Oncodesign, Sanofi ink research collaboration and license agreement

Friday, September 14, 2012 11:57 AM

Oncodesign, a French drug discovery company and oncology pharmacology service provider, has entered into a strategic research collaboration with global healthcare company Sanofi to apply Oncodesign's Nanocyclix technology to Sanofi kinase target programs.

More... »

Sweden to invest $320 million in life sciences

Wednesday, September 12, 2012 10:41 AM

A delegation of four ministers from the Swedish government, led by the Prime Minister Fredrik Reinfeldt, confirmed the country's largest ever investment in life sciences as a key element of the ruling coalition's autumn budget and research and innovation bill.

More... »

F2G completes $30M financing round for anti-fungal compounds

Thursday, September 6, 2012 07:48 AM

F2G, an antifungal drug discovery and development company based in Manchester, U.K., has completed a $30 million equity financing round, which will be used to select a clinical candidate from the F3 series of advanced preclinical analogs and proceed to first in man studies.

More... »